ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

A Dual Approach with Organoid and CRISPR Screening Reveals ERCC6 as a Determinant of Cisplatin Resistance in Osteosarcoma.

Ruiling Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.